Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal Salmonella Infections: A Population-Based Cohort Study
- PMID: 38567440
- DOI: 10.1093/ibd/izae053
Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal Salmonella Infections: A Population-Based Cohort Study
Abstract
Background: Despite the known association between microorganisms and development of inflammatory bowel disease (IBD), the role of nontyphoidal Salmonella (NTS) in IBD is not adequately addressed. We aimed at elucidating the relationship between NTS infection and the risk of IBD.
Methods: Based on the National Health Insurance Research Database in Taiwan, this retrospective cohort study enrolled patients with NTS infection (exposure group; n = 4651) and those without NTS infection (comparator group; n = 4651) who were propensity score matched (1:1) by demographic data, medications, comorbidities, and index date. All patients were followed until IBD onset, individual mortality, or December 31, 2018. Cox proportional hazards regression analysis was performed to determine the hazard ratios and 95% confidence intervals (CIs). Sensitivity analyses were used for cross-validation.
Results: The NTS group demonstrated an increased risk of IBD compared with the non-NTS groups (adjusted hazard ratio [aHR], 2.12; 95% CI, 1.62-2.78) with a higher risk of developing ulcerative colitis in the former (aHR, 2.27; 95% CI, 1.69-3.04). Nevertheless, the small sample size may contribute to lack of significant difference in Crohn's disease. Consistent findings were noted after excluding IBD diagnosed within 6 months of NTS infection (aHR, 2.28; 95% CI, 1.71-3.03), excluding those with enteritis/colitis before index date (aHR, 1.85; 95% CI, 1.28-2.68), excluding those using antibiotics for 1 month in the year before IBD onset (aHR, 1.81; 95% CI, 1.34-2.45), inverse probability of treatment weighting (aHR, 1.64; 95% CI, 1.31-2.04), and inclusion of individuals regardless of age (n = 10 431; aHR, 1.83; 95% CI, 1.53-2.19).
Conclusions: Patients with NTS were associated with an increased risk of developing IBD, especially ulcerative colitis.
Keywords: Crohn’s disease; IBD; NTS; cohort study; inflammatory bowel disease; nontyphoidal Salmonella; ulcerative colitis.
© The Author(s) 2024. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Comment in
-
Non-Typhoidal Salmonella Infections and Inflammatory Bowel Disease Risk: New Findings and Multidimensional Perspectives for Future Research.Inflamm Bowel Dis. 2025 May 5:izaf082. doi: 10.1093/ibd/izaf082. Online ahead of print. Inflamm Bowel Dis. 2025. PMID: 40326745 No abstract available.
Similar articles
-
Enteric Salmonella or Campylobacter infections and the risk of inflammatory bowel disease.Gut. 2011 Mar;60(3):318-24. doi: 10.1136/gut.2010.223396. Epub 2010 Dec 29. Gut. 2011. PMID: 21193449
-
Risk of acute myocardial infarction in patients with non-typhoidal Salmonella infection: A nationwide matched population-based cohort study.Public Health. 2025 May;242:406-412. doi: 10.1016/j.puhe.2025.03.019. Epub 2025 Apr 10. Public Health. 2025. PMID: 40215913
-
Nontyphoidal Salmonella Infection Associated with Subsequent Risk of Hematological Malignancies: A Nationwide Population-Based Cohort Study.Int J Environ Res Public Health. 2022 Oct 10;19(19):12943. doi: 10.3390/ijerph191912943. Int J Environ Res Public Health. 2022. PMID: 36232242 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
The role of antibiotic exposure as risk factor for IBD epidemic: an updated meta-analysis.J Gastroenterol Hepatol. 2024 Dec;39(12):2561-2571. doi: 10.1111/jgh.16751. Epub 2024 Oct 16. J Gastroenterol Hepatol. 2024. PMID: 39415308 Review.
Cited by
-
Emerging Strategies against Non-Typhoidal Salmonella: From Pathogenesis to Treatment.Curr Issues Mol Biol. 2024 Jul 14;46(7):7447-7472. doi: 10.3390/cimb46070442. Curr Issues Mol Biol. 2024. PMID: 39057083 Free PMC article. Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical